
Nanobiotix SA
PAR:NANO

Fundamental Analysis


Revenue & Expenses Breakdown
Nanobiotix SA
Balance Sheet Decomposition
Nanobiotix SA
Current Assets | 61.5m |
Cash & Short-Term Investments | 49.7m |
Receivables | 8.5m |
Other Current Assets | 3.2m |
Non-Current Assets | 6m |
Long-Term Investments | 406k |
PP&E | 5.5m |
Intangibles | 7k |
Other Non-Current Assets | 1k |
Free Cash Flow Analysis
Nanobiotix SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Nanobiotix SA
Revenue
|
-11.6m
EUR
|
Operating Expenses
|
-56.8m
EUR
|
Operating Income
|
-68.4m
EUR
|
Other Expenses
|
260k
EUR
|
Net Income
|
-68.1m
EUR
|
NANO Profitability Score
Profitability Due Diligence
Nanobiotix SA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Score
Nanobiotix SA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
NANO Solvency Score
Solvency Due Diligence
Nanobiotix SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Score
Nanobiotix SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NANO Price Targets Summary
Nanobiotix SA
According to Wall Street analysts, the average 1-year price target for
NANO
is 11.41 EUR
with a low forecast of 8.08 EUR and a high forecast of 17.85 EUR.
Dividends
Current shareholder yield for NANO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?